Exscientia’s USD 1.2 Billion Collaboration With Bristol Myers Squibb

Allen & Overy has advised Exscientia on the deal.The collaboration will use AI to accelerate the discovery of small molecule therapeutic drug candidates in multiple therapeutic…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

This content is for Standard 1 Year members only.
Login Join Now